European manufacturing sites

FINE CHEMICALS FOR PHARMACEUTICALS

from R&D to Pilot and Industrial

more information

More than 160 reactors running

Capacity up to 1100m3

750 high specialized employees

Fabrication from R&D to pilot, to Industrial scale

Skills

Sites of Moehs group

Learn More

High quality

standards

Quality Assurance

Regulatory Affairs

Technical Assistance

Quality Control

Sites approval: FDA, J-PMDA, C-FDA, KFDA, TGA, EMA

GMP & ICH Q7A compliance

Compliance to USP, Eur. Ph., JP, ND

More than 30 CEPS issued

European manufacturing sites

Sites of Moehs group

Learn More

Skills

More than 160 reactors running

Capacity up to 1100m3

750 high specialized employees

Fabrication from R&D to pilot, to Industrial scale

High quality standards

Sites approval: FDA, J-PMDA, C-FDA, KFDA, TGA, EMA GMP & ICH Q7A compliance Compliance to USP, Eur. Ph., JP, ND More than 30 CEPS issued

Quality Assurance

Regulatory Affairs

Technical Assistance

Quality Control

FINE CHEMICALS FOR PHARMACEUTICALS

from R&D to Pilot and Industrial

more information

Go to article: Home | The deep dive for new drugsGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Hapa Company InsightGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Owen MumfordGo to article: The pharma industry briefingGo to article: Capsugel Company InsightGo to article: Swiss WorldCargoGo to article: In the age of AMR, does a nationalised drug company make sense? The case for and againstGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Underwater forests and the search for natures’ next drug treasure troveGo to article: Barc Lab Go to article: BEAGo to article: Developing drugs for NASH: the race to market Go to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Zulresso: the world’s first post-partum depression drugGo to article: EcocoolGo to article: Moehs Iberica SLGo to article: Predicting drug flops with AIGo to article: Abiogen PharmaGo to article: LaudaGo to article: Proteomics and the promise of ‘enriching’ clinical trials Go to article: Lubrizol Life SciencesGo to article: SkycellGo to article: EventsGo to article: TemptimeGo to article: Next issueGo to article: Pfanstiehl Company InsightGo to article: Pfanstiehl